Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1987 | 12-1986 | 12-1985 | 12-1984 | 12-1983 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,865 | 3,573 | N/A | N/A | N/A |
| Marketable Securities | 2,922 | 5,256 | N/A | N/A | N/A |
| Receivables | 733 | 510 | N/A | N/A | N/A |
| Inventories | 437 | 190 | N/A | N/A | N/A |
| Other current assets | 209 | 24 | 0 | 0 | 0 |
| TOTAL | $8,167 | $9,552 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,097 | 2,638 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,772 | 165 | 0 | 0 | 0 |
| TOTAL | $5,869 | $2,803 | $N/A | $N/A | $N/A |
| Total Assets | $14,036 | $12,355 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 423 | 101 | 0 | 0 | 0 |
| Accrued Expenses | 109 | 13 | N/A | N/A | N/A |
| Other current liabilities | 15 | 83 | N/A | N/A | N/A |
| TOTAL | $609 | $273 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $190 | $36 | $N/A | $N/A | $N/A |
| Total Liabilities | $798 | $309 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 29 | 30 | N/A | N/A | N/A |
| Retained earnings | 3,027 | 2,176 | N/A | N/A | N/A |
| TOTAL | $13,238 | $12,046 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $14,036 | $12,355 | $0 | $0 | $0 |